Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study.

Breast Cancer Res Treat · 2024 · PMC11297052 · PMID 38763971

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

One of our main findings was that the cumulative exposure to beta-blockers did appear to reduce the risk of invasive breast cancer in a dose-dependent manner, though the associations did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.